Cargando…
Could decorin be a biomarker of coronary artery disease? A pilot study in human beings
Background and aim: Nowadays there is a strong necessity in identifying patients who may be exposed to the risk for future cardiovascular events like progressive atherosclerotic disease. Biomarkers are valuable tools for this purpose. Coronary artery calcification (CAC) is utilized as an important t...
Autores principales: | Saeed, Nazemi, Atefeh, Rezapour, Seyed, Mohammad Hassan Moallem, Mohammad, Afshar, Sepideh, Elyasi, Hamid, Reza Mashreghi Moghadam, Mahmoud, Dargahi Zaboli, Amir, Hooshang Mohammadpour |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502117/ https://www.ncbi.nlm.nih.gov/pubmed/30333460 http://dx.doi.org/10.23750/abm.v89i3.6024 |
Ejemplares similares
-
Evaluation of NPP1 as a Novel Biomarker of Coronary Artery Disease: A Pilot Study in Human Beings
por: Mohammadpour, Amir Hooshang, et al.
Publicado: (2018) -
Teratogenic Effects of Pregabalin in Mice
por: Etemad, Leila, et al.
Publicado: (2013) -
A Review on Therapeutic Drug Monitoring of Immunosuppressant Drugs
por: Mohammadpour, Niloufar, et al.
Publicado: (2011) -
A novel atheroprotective role of MF59-like adjuvant when co-administered with CETP vaccine in rabbit model of atherosclerosis
por: Aghebati, Tamara, et al.
Publicado: (2016) -
Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review
por: Sharifzadeh, Shiva, et al.
Publicado: (2020)